MINERALYS THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
MINERALYS THERAPEUTICS, INC. (MLYS) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $244.60 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $244.60M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $69.00M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $35.00M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $25.70M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $244.60M 10-K · filed 2026-03-12 |
| 2024-12-31 | $69.00M 10-K · filed 2026-03-12 |
| 2023-12-31 | $35.00M 10-K · filed 2025-02-12 |
| 2022-12-31 | $25.70M 10-K · filed 2024-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |